8329 — Shenzhen Neptunus Interlong Bio-technique Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$251.70m
- HK$289.29m
- CNY1.04bn
- 48
- 78
- 47
- 63
Annual cashflow statement for Shenzhen Neptunus Interlong Bio-technique Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 50.2 | 39.1 | 82.3 | 30.7 | 29.6 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 17.5 | 4.11 | 6.09 | 28.2 | 11.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.24 | -143 | -63.1 | -38.9 | -51.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 93.6 | -69.9 | 61.2 | 53.7 | 24.4 |
| Capital Expenditures | -38 | -15.1 | -19.7 | -15.4 | -22.2 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 7.27 | -166 | 30.5 | 76.3 | -92.4 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -30.7 | -182 | 10.8 | 60.9 | -115 |
| Financing Cash Flow Items | -3.75 | 20.5 | 10.9 | -29.2 | -8.69 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -35.3 | 66.7 | -9.02 | -32.5 | 1.43 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 27.7 | -185 | 63 | 82.1 | -88.8 |